Section Arrow
DERM.NASDAQ
- Journey Medical Corp
Quotes are at least 15-min delayed:2025/05/11 02:34 EDT
Last
 6.88
0 (0.00%)
Day High 
7.04 
Prev. Close
6.88 
1-M High
7.84 
Volume 
96.39K 
Bid
6.85
Ask
7.21
Day Low
6.81 
Open
6.92 
1-M Low
5.7244 
Market Cap 
158.96M 
Currency USD 
P/E 39.69 
%Yield -- 
10-SMA 7.11 
20-SMA 6.84 
50-SMA 6.2 
52-W High 7.84 
52-W Low 3.2001 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.72/2.18
Enterprise Value
183.96M
Balance Sheet
Book Value Per Share
0.87
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
56.13M
Operating Revenue Per Share
2.66
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SHPHShuttle Pharmaceuticals Holdings Inc0.2325-0.0375-13.89%-- 
PTPIPetros Pharmaceuticals Inc0.1201-0.0053-4.23%-- 
VTRSViatris8.77-0.32-3.52%227.2PE
TEVATeva Pharmaceutical Industries Limited16.93-1.14-6.31%-- 
IXHLIncannex Healthcare0.1135+0.0009+0.80%-- 
Quotes are at least 15-min delayed:2025/05/11 02:34 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.